California Inches Closer to Business Climate for Biotech Growth

Addressing the importance of job creation, BayBio and Assemblyman Jerry Hill announced legislation to retain and attract California's second largest employing industry during a press conference at Xdx’s R&D lab in Brisbane, California. Hill’s proposal would create a director of biotechnology in the governor’s office. It would be another step to build on the momentum the state has generated in the last several years. A key proposal passed in 2009 removed a penalty to build facilities in the state. The Single Sales Factor tax apportionment formula removed state taxes on facilities and payrolls of companies operating in California. In 2008, the legislature extended Net Operating Loss (NOL) carry forward from 10 years to 20 years.

California Biomedical Jobs Holding Steady

The California Healthcare Institute and PricewaterhouseCoopers have just released the 2010 California Biomedical Industry Report, which shows that the state’s 274,000 biomedical industry jobs are holding steady. The biomedical industry is one of the most recession-resilient sectors in California’s hard-hit economy and a critical driver of innovation, job growth and revenue that will help lead the state to economic recovery. To read the full report, please visit www.chi.org for more information.

February 9 Medical Device Breakfast Series | Company Valuation for M&A
February 11 Venture Spotlight | A Sweet Deal: How to Attract Investors
February 24 Executive Series | CEO & CFO Roundtable: What’s Ahead for the Biotech IPOs
February 24 SBIR-STTR Grant Writing Workshop
February 25 Therapeutic Breakfast | Clinical Trials Abroad: Options for Smaller Companies with Limited Funds
March 11 BayBio NEST | Heart Matters: Investments in Heart Disease
March 17 BayBio NEST | 7th Annual Life Sciences Investors & Entrepreneur Roundtables
March 23 BioFacilities | Industry Knowledge for the Non-Scientist
March 25 Therapeutic Breakfast Series | Establishing and Successfully Managing Strategic Alliances
April 7 BayBio2010 | Life Science Innovation: Drivers and Barriers
April 29 BayBio NEST | Technology Showcase at SRI International
May 12 BayBio Executive Series | Managing the Board
May 19 California Life Sciences Day

Takeda San Francisco
Center for Excellence in Therapeutic Antibody Research

Takeda San Francisco, Inc.(TSF) is Takeda's global center for excellence for biologics. TSF was established in November 2007 and supports Takeda's therapeutic antibody research through our antibody technology platform. This platform is based on discovery, optimization and development technologies used to efficiently generate Investigational New Drug (IND) candidates for the treatment of cancer, inflammatory and metabolic diseases.

• Learn more about Takeda San Francisco